DAT has been involved in the etiology and treatment of various neurologic disorders including schizophrenia, attention deficit hyperactivity disorder (ADHD) and Parkinson’s disease (Miller et al., 1999; Wang et al., 2013; Markota et al., 2014). This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.